Tocilizumab is recommended for the treatment of severe COVID-19

被引：3
|
作者：
Zhou, Yonggang [1 ,2 ,3 ,4 ,5 ]
Wei, Haiming [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Hefei 230001, Anhui, Peoples R China
[2] Univ Sci & Technol China, Sch Basic Med, Inst Immunol, Hefei 230001, Anhui, Peoples R China
[3] Univ Sci & Technol China, Sch Basic Med, CAS Key Lab Innate Immun & Chron Dis, Hefei 230001, Anhui, Peoples R China
[4] Univ Sci & Technol China, Med Ctr, Hefei 230001, Anhui, Peoples R China
[5] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230001, Anhui, Peoples R China
来源：
EBIOMEDICINE | 2020年 / 61卷
关键词：
D O I：
10.1016/j.ebiom.2020.103045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tocilizumab in severe COVID-19
    Liberato, Nicola Lucia
    De Monte, Andrea
    Caravella, Giuseppe
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1457 - 1458
  • [2] Effective treatment of severe COVID-19 patients with tocilizumab
    Xu, Xiaoling
    Han, Mingfeng
    Li, Tiantian
    Sun, Wei
    Wang, Dongsheng
    Fu, Binqing
    Zhou, Yonggang
    Zheng, Xiaohu
    Yang, Yun
    Li, Xiuyong
    Zhang, Xiaohua
    Pan, Aijun
    Wei, Haiming
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) : 10970 - 10975
  • [3] Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
    Wang, Yong
    Chen, Yongfeng
    Zhou, Xiangdong
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [4] Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
    Samaee, Hamidreza
    Mohsenzadegan, Monireh
    Ala, Shahram
    Maroufi, Shahnam Sedigh
    Moradimajd, Parisa
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [5] Tocilizumab for severe COVID-19 pneumonia
    Mourad, Jean-Jacques
    Azria, Philippe
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (11): : E659 - E659
  • [6] Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19
    Cawcutt, Kelly A.
    Kalil, Andre C.
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (03) : 413 - 415
  • [7] Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Reid, Nancy Kierstin
    Joyner, Kayla Rena
    Lewis-Wolfson, Temeka Dawn
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (07) : 769 - 775
  • [8] Why tocilizumab could be an effective treatment for severe COVID-19?
    Binqing Fu
    Xiaoling Xu
    Haiming Wei
    [J]. Journal of Translational Medicine, 18
  • [9] Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19
    Singla, Karan
    Puri, Goverdhan D.
    Niyogi, Subhrashis Guha
    Mahajan, Varun
    Kajal, Kamal
    Bhalla, Ashish
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [10] Why tocilizumab could be an effective treatment for severe COVID-19?
    Fu, Binqing
    Xu, Xiaoling
    Wei, Haiming
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
12345